Back to Trades
Grant4
TG THERAPEUTICS, INC.
TGTX
Total Value
$0
Company Information
- Company Name
- TG THERAPEUTICS, INC.
- Ticker Symbol
- TGTX
- CIK
- 0001001316
Insider Information
- Name
- WEISS MICHAEL S
- Role
- CEO, Director
- Location
- MORRISVILLE, NC
DirectorOfficer
Filing Details
- Filing Date
- Jan 9, 2026
- Transaction Date
- Jan 8, 2026
- Accession Number
- 0001437749-26-001016
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Jan 8, 2026 | Common Stock | 622,000 | — | Grant/Award | — |
Footnotes
- (F1)Reflects a grant of restricted shares, all of which will vest on the first anniversary of the date on which the first of any of the following occur: (i) the Company's total shareholder return (TSR) exceeds the TSR of the Nasdaq Biotechnology Index (NBI) over a 3-year period; (ii) the Company's TSR exceeds the TSR of the NBI over a 5-year period; (iii) the Company's TSR exceeds the TSR of the NBI over a 7-year period; or (iv) the Company's TSR exceeds the TSR of the NBI over a 9-year period.
- (F2)Includes shares of restricted Common Stock, which vest over various time periods.